Gerresheimer AG (GXI) - Cash Flow Conversion Efficiency

Latest as of May 2025: 0.042x

Based on the latest financial reports, Gerresheimer AG (GXI) has a cash flow conversion efficiency ratio of 0.042x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.03 Million ≈ $72.51 Million USD) by net assets (€1.47 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Gerresheimer AG - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Gerresheimer AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GXI total liabilities for a breakdown of total debt and financial obligations.

Gerresheimer AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gerresheimer AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hichain Logistics Co Ltd
SHE:300873
0.031x
Shanghai Yongmaotai Automotive Technology Co. Ltd.
SHG:605208
-0.027x
REVO INSURANCE SPA O.N.
F:H0O
N/A
Western Regions Tourism Development
SHE:300859
0.074x
Start Group
SHG:600734
-0.057x
China Bills Finance Corp
TW:2820
0.022x
BELL AGROMACHINA ORD T (BSE)
NSE:BALUFORGE
0.032x
Nanjing Port Co Ltd
SHE:002040
0.024x

Annual Cash Flow Conversion Efficiency for Gerresheimer AG (2013–2024)

The table below shows the annual cash flow conversion efficiency of Gerresheimer AG from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Gerresheimer AG stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-11-30 €1.54 Billion
≈ $1.80 Billion
€240.33 Million
≈ $280.97 Million
0.156x -21.89%
2023-11-30 €1.47 Billion
≈ $1.72 Billion
€294.34 Million
≈ $344.11 Million
0.200x +14.34%
2022-11-30 €1.27 Billion
≈ $1.48 Billion
€221.94 Million
≈ $259.47 Million
0.175x -17.37%
2021-11-30 €1.00 Billion
≈ $1.17 Billion
€212.08 Million
≈ $247.94 Million
0.212x -14.32%
2020-11-30 €899.66 Million
≈ $1.05 Billion
€222.19 Million
≈ $259.77 Million
0.247x +20.53%
2019-11-30 €941.56 Million
≈ $1.10 Billion
€192.92 Million
≈ $225.55 Million
0.205x +5.14%
2018-11-30 €890.13 Million
≈ $1.04 Billion
€173.47 Million
≈ $202.81 Million
0.195x -29.79%
2017-11-30 €789.52 Million
≈ $923.04 Million
€219.16 Million
≈ $256.22 Million
0.278x +22.13%
2016-11-30 €763.29 Million
≈ $892.37 Million
€173.49 Million
≈ $202.82 Million
0.227x -22.13%
2015-11-30 €698.13 Million
≈ $816.19 Million
€203.78 Million
≈ $238.24 Million
0.292x +11.45%
2014-11-30 €604.37 Million
≈ $706.57 Million
€158.29 Million
≈ $185.05 Million
0.262x +0.60%
2013-11-30 €563.40 Million
≈ $658.68 Million
€146.68 Million
≈ $171.48 Million
0.260x --

About Gerresheimer AG

F:GXI Germany Medical Instruments & Supplies
Market Cap
$990.95 Million
€847.61 Million EUR
Market Cap Rank
#10771 Global
#1239 in Germany
Share Price
€24.54
Change (1 day)
+5.23%
52-Week Range
€15.51 - €64.30
All Time High
€120.00
About

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more